Antibacterial Market

- Size, Trend, Share, Opportunity Analysis, and Forecast, 2014-2025

  • Date Materials and Chemicals
  • Date July 2017
  • price $3619
 
 

Antibacterial medications allude to the substances that can obliterate or hinder the development of microorganisms such as microbes. Antibacterial medications are frequently named as anti-microbial and are generally utilized as a part of anticipation and treatment of unavoidable diseases. Different classes of these medications have been created, as indicated by the microorganisms to be checked. Advertisements for antibacterial medications are driven by the expanding predominance of unavoidable maladies.

Growth in aged population, increasing demand for effective & affordable antibacterial drugs, and the growing quantity of multi-drug resistant bacterial strains are some of the driving factors of the global antibacterial market. The high prevalence of communicable diseases, which demand for the progress of innovative molecules or behavior, boosts the antibacterial market. However, the increasing number of common drugs for antibacterial activities and patent terminations hamper the growth of the antibacterial market.

The market is segmented based on class and geography. Based on class, the market is classified into aminoglycosides, tetracyclines, macrolides, B-Lactams, quinolones/ fluoroquinolones, sulfonamides, phenicols, and miscellaneous antibacterials. The geographic breakdown and deep analysis of each of the previously mentioned segments have been covered for North America, Europe, Asia-Pacific, and LAMEA.

Market Dynamics:

Drivers:

  • Availability of antibacterial drugs
  • Improving economy in emerging economies
  • Increasing number of multi-drug resistant bacterial strains

Restraints:

  • Patent expiries
  • Availability of generic drugs

Market Players:

The top players in the global antibacterial market are Pfizer, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bayer AG, Sanofi, AstraZeneca plc, and Bristol-Myers Squibb Company.

KEY TAKEAWAYS

antibacterial market

MARKET LANDSCAPE

By Class

  • Aminoglycosides
  • B-Lactams
  • Tetracyclines
  • Sulfonamides
  • Quinolones/ Fluoroquinolones
  • Macrolides
  • Phenicols
  • Pipeline Drugs
  • Miscellaneous Antibacterials

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Africa
    • Saudi Arabia
    • Rest of LAMEA
1. Executive Summary
1.1. Key Findings
1.2. Market Attractiveness and Trend analysis
1.3. Competitive Landscape and Recent Industry Development Analysis
2. Introduction
2.1. Report Description
2.2. Scope and Definitions
2.3. Research Methodology
3. Market Landscape
3.1. Growth Drivers
3.1.1. Impact analysis
3.2. Restrains and Challenges
3.2.1. Impact analysis
3.3. Porter’s Analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global Antibacterial Market Shares Analysis, 2014-2025
3.4.1. Global Antibacterial market share by class, 2014-2025
3.4.2. Global Antibacterial market share by geography, 2014-2025
4. Market by Class
4.1. Aminoglycosides
4.1.1. Historical market size by Region, 2014-2016
4.1.2. Market forecast by Region, 2017-2025
4.2. B-Lactams
4.2.1. Historical market size by Region, 2014-2016
4.2.2. Market forecast by Region, 2017-2025
4.3. Tetracyclines
4.3.1. Historical market size by Region, 2014-2016
4.3.2. Market forecast by Region, 2017-2025
4.4. Sulfonamides
4.4.1. Historical market size by Region, 2014-2016
4.4.2. Market forecast by Region, 2017-2025
4.5. Quinolones/ Fluoroquinolones
4.5.1. Historical market size by Region, 2014-2016
4.5.2. Market forecast by Region, 2017-2025
4.6. Macrolides
4.6.1. Historical market size by Region, 2014-2016
4.6.2. Market forecast by Region, 2017-2025
4.7. Phenicols
4.7.1. Historical market size by Region, 2014-2016
4.7.2. Market forecast by Region, 2017-2025
4.8. Pipeline Drugs
4.8.1. Historical market size by Region, 2014-2016
4.8.2. Market forecast by Region, 2017-2025
4.9. Miscellaneous Antibacterial
4.9.1. Historical market size by Region, 2014-2016
4.9.2. Market forecast by Region, 2017-2025
5. Market by Geography
5.1. North America
5.1.1. U.S.
5.1.1.1. Historical market size, 2014-2016
5.1.1.2. Market forecast, 2017-2025
5.1.2. Canada
5.1.2.1. Historical market size, 2014-2016
5.1.2.2. Market forecast, 2017-2025
5.1.3. Mexico
5.1.3.1. Historical market size, 2014-2016
5.1.3.2. Market forecast, 2017-2025
5.2. Europe
5.2.1. UK
5.2.1.1. Historical market size, 2014-2016
5.2.1.2. Market forecast, 2017-2025
5.2.2. Germany
5.2.2.1. Historical market size, 2014-2016
5.2.2.2. Market forecast, 2017-2025
5.2.3. France
5.2.3.1. Historical market size, 2014-2016
5.2.3.2. Market forecast, 2017-2025
5.2.4. Spain
5.2.4.1. Historical market size, 2014-2016
5.2.4.2. Market forecast, 2017-2025
5.2.5. Italy
5.2.5.1. Historical market size, 2014-2016
5.2.5.2. Market forecast, 2017-2025
5.2.6. Russia
5.2.6.1. Historical market size, 2014-2016
5.2.6.2. Market forecast, 2017-2025
5.2.7. Rest of Europe
5.2.7.1. Historical market size, 2014-2016
5.2.7.2. Market forecast, 2017-2025
5.3. Asia-Pacific
5.3.1. China
5.3.1.1. Historical market size, 2014-2016
5.3.1.2. Market forecast, 2017-2025
5.3.2. Japan
5.3.2.1. Historical market size, 2014-2016
5.3.2.2. Market forecast, 2017-2025
5.3.3. India
5.3.3.1. Historical market size, 2014-2016
5.3.3.2. Market forecast, 2017-2025
5.3.4. Australia
5.3.4.1. Historical market size, 2014-2016
5.3.4.2. Market forecast, 2017-2025
5.3.5. South Korea
5.3.5.1. Historical market size, 2014-2016
5.3.5.2. Market forecast, 2017-2025
5.3.6. Rest of Asia-Pacific
5.3.6.1. Historical market size, 2014-2016
5.3.6.2. Market forecast, 2017-2025
5.4. LAMEA
5.4.1. Brazil
5.4.1.1. Historical market size, 2014-2016
5.4.1.2. Market forecast, 2017-2025
5.4.2. Argentina
5.4.2.1. Historical market size, 2014-2016
5.4.2.2. Market forecast, 2017-2025
5.4.3. Africa
5.4.3.1. Historical market size, 2014-2016
5.4.3.2. Market forecast, 2017-2025
5.4.4. Saudi Arabia
5.4.4.1. Historical market size, 2014-2016
5.4.4.2. Market forecast, 2017-2025
5.4.5. Rest of LAMEA
5.4.5.1. Historical market size, 2014-2016
5.4.5.2. Market forecast, 2017-2025
6. Company Profiles
6.1. Pfizer, Inc.
6.1.1. Overview
6.1.2. Financials and business segments
6.1.3. Recent developments
6.2. GlaxoSmithKline Plc
6.2.1. Overview
6.2.2. Financials and business segments
6.2.3. Recent developments
6.3. Merck & Co., Inc.
6.3.1. Overview
6.3.2. Financials and business segments
6.3.3. Recent developments
6.4. Novartis AG
6.4.1. Overview
6.4.2. Financials and business segments
6.4.3. Recent developments
6.5. Johnson & Johnson
6.5.1. Overview
6.5.2. Financials and business segments
6.5.3. Recent developments
6.6. Eli Lilly and Company
6.6.1. Overview
6.6.2. Financials and business segments
6.6.3. Recent developments
6.7. Bayer AG
6.7.1. Overview
6.7.2. Financials and business segments
6.7.3. Recent developments
6.8. Sanofi
6.8.1. Overview
6.8.2. Financials and business segments
6.8.3. Recent developments
6.9. AstraZeneca plc
6.9.1. Overview
6.9.2. Financials and business segments
6.9.3. Recent developments
6.10. Bristol-Myers Squibb Company
6.10.1. Overview
6.10.2. Financials and business segments
6.10.3. Recent developments

List of Tables

Table 1. Antibacterial Market Value, by Class, 2014-2025, $million
Table 2. Aminoglycosides Antibacterial Market Value, by Region, 2017-2025, $million
Table 3.B-Lactams Antibacterial Market Value, by Region, 2017-2025, $million
Table 4. Tetracyclines Antibacterial Market Value, by Region, 2017-2025, $million
Table 5. Sulfonamides Antibacterial Market Value, by Region, 2017-2025, $million
Table 6. Quinolones/ Fluoroquinolones Antibacterial Market Value, by Region, 2017-2025, $million
Table 7. Macrolides Antibacterial Market Value, by Region, 2017-2025, $million
Table 8. Phenicols Antibacterial Market Value, by Region, 2017-2025, $million
Table 9. Pipeline Drugs Antibacterial Market Value, by Region, 2017-2025, $million
Table 10. Miscellaneous Antibacterial Market Value, by Region, 2017-2025, $million
Table 11. Antibacterial Market Value for North America, by Country, 2014-2025, $million
Table 12. Antibacterial Market Value for North America, by Class, 2014-2025, $million
Table 13. Antibacterial Market Value for Europe, by Country, 2014-2025, $million
Table 14. Antibacterial Market Value for Europe, by Class, 2014-2025, $million
Table 15. Antibacterial Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 16. Antibacterial Market Value for Asia-Pacific, by Class, 2014-2025, $million
Table 17. Antibacterial Market Value for LAMEA, by Country, 2014-2025, $million
Table 18. Antibacterial Market Value for LAMEA, by Class, 2014-2025, $million
Table 19. Pfizer, Inc. - Company Snapshot
Table 20. GlaxoSmithKline Plc - Company Snapshot
Table 21. Merck & Co., Inc. - Company Snapshot
Table 22. Novartis AG - Company Snapshot
Table 23. Johnson & Johnson - Company Snapshot
Table 24. Eli Lilly and Company - Company Snapshot
Table 25. Bayer AG - Company Snapshot
Table 26. Sanofi - Company Snapshot
Table 27. AstraZeneca Plc - Company Snapshot
Table 28. Bristol-Myers Squibb Company - Company Snapshot

List of figures

Figure 1. Aminoglycosides Antibacterial Market Value, 2014-2016, $million
Figure 2. B-Lactams Antibacterial Market Value, 2014-2016, $million
Figure 3. Tetracyclines Antibacterial Market Value, 2014-2016, $million
Figure 4. Sulfonamides Antibacterial Market Value, 2014-2016, $million
Figure 5. Quinolones/ Fluoroquinolones Antibacterial Market Value, 2014-2016, $million
Figure 6. Macrolides Antibacterial Market Value, 2014-2016, $million
Figure 7. Phenicols Antibacterial Market Value, 2014-2016, $million
Figure 8. Pipeline Drugs Antibacterial Market Value, 2014-2016, $million
Figure 9. Miscellaneous Antibacterial Market Value, 2014-2016, $million
Figure 10. Antibacterial: U.S. Market Value, 2014-2016, $million
Figure 11. Antibacterial: U.S. Market Value, 2017-2025, $million
Figure 12. Antibacterial: Canada Market Value, 2014-2016, $million
Figure 13. Antibacterial: Canada Market Value, 2017-2025, $million
Figure 14. Antibacterial: Mexico Market Value, 2014-2016, $million
Figure 15. Antibacterial: Mexico Market Value, 2017-2025, $million
Figure 16. Antibacterial: UK Market Value, 2014-2016, $million
Figure 17. Antibacterial: UK Market Value, 2017-2025, $million
Figure 18. Antibacterial: Germany Market Value, 2014-2016, $million
Figure 19. Antibacterial: Germany Market Value, 2017-2025, $million
Figure 20. Antibacterial: France Market Value, 2014-2016, $million
Figure 21. Antibacterial: France Market Value, 2017-2025, $million
Figure 22. Antibacterial: Spain Market Value, 2014-2016, $million
Figure 23. Antibacterial: Spain Market Value, 2017-2025, $million
Figure 24. Antibacterial: Italy Market Value, 2014-2016, $million
Figure 25. Antibacterial: Italy Market Value, 2017-2025, $million
Figure 26. Antibacterial: Russia Market Value, 2014-2016, $million
Figure 27. Antibacterial: Russia Market Value, 2017-2025, $million
Figure 28. Antibacterial: Rest of Europe Market Value, 2014-2016, $million
Figure 29. Antibacterial: Rest of Europe Market Value, 2017-2025, $million
Figure 30. Antibacterial: China Market Value, 2014-2016, $million
Figure 31. Antibacterial: China Market Value, 2017-2025, $million
Figure 32. Antibacterial: Japan Market Value, 2014-2016, $million
Figure 33. Antibacterial: Japan Market Value, 2017-2025, $million
Figure 34. Antibacterial: India Market Value, 2014-2016, $million
Figure 35. Antibacterial: India Market Value, 2017-2025, $million
Figure 36. Antibacterial: Australia Market Value, 2014-2016, $million
Figure 37. Antibacterial: Australia Market Value, 2017-2025, $million
Figure 38. Antibacterial: South Korea Market Value, 2014-2016, $million
Figure 39. Antibacterial: South Korea Market Value, 2017-2025, $million
Figure 40. Antibacterial: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 41. Antibacterial: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 42. Antibacterial: Brazil Market Value, 2014-2016, $million
Figure 43. Antibacterial: Brazil Market Value, 2017-2025, $million
Figure 44. Antibacterial: Argentina Market Value, 2014-2016, $million
Figure 45. Antibacterial: Argentina Market Value, 2017-2025, $million
Figure 46. Antibacterial: Africa Market Value, 2014-2016, $million
Figure 47. Antibacterial: Africa Market Value, 2017-2025, $million
Figure 48. Antibacterial: Saudi Arabia Market Value, 2014-2016, $million
Figure 49. Antibacterial: Saudi Arabia Market Value, 2017-2025, $million
Figure 50. Antibacterial: Rest of LAMEA Market Value, 2014-2016, $million
Figure 51. Antibacterial: Rest of LAMEA Market Value, 2017-2025, $million Value
License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Are You?

  • Startup
  • Student or University
  • Research Scholar
  • Government Agencies
  • Non-profit Organization
  • NGO / Self Help Group
  • First Time Buyer

Get Discount     btn-arrow

Please Select Format

Need More Information

Why Progressive Markets

The market research services provided by Progressive Markets are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews with industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Markets holds no responsibility for misleading or false information gathered from these sources.

Progressive Markets understands and respects the privacy of persona

Recently Viewed Reports

Similar Market Research Report

blog
Sep
2017
Global In Vitro Fertilization (IVF) Services Market

In vitro fertilization (IVF) is an artificial fertilization process that is performed in the laboratory under artificial environment. The colloquial term for babies conceived through the IVF procedures is test-tube ... Read More >>

 

Get Email Alert